US insurer Blue Cross Blue Shield agrees to a $2.8bn antitrust settlement to resolve claims of underpayment to healthcare providers, leading to increased insurance costs. The agreement awaits approval from a US district judge, impacting providers and patients from July 2008 to October 2024.